Humana Inc.'s (NYSE:HUM) shares have seen activities from different institutions, and the company has had a tumultuous run in the stock market.
Fifth Third Bancorp and
Manning & Napier Advisors LLC sold their shares while
Factory Mutual Insurance Co. took a $5.48 Million position. With Humana soaring 3.1%, investors wonder if further upside is left. Some hurdles affected Humana's performance in Q3, and AM Best downgraded the credit ratings of Humana Health of Puerto Rico Groupβs Subsidiaries, while affirming Humana Inc. However,
Humana announced the date of Q4 2024 earnings release and 2025 financial guidance, indicating strategic preparation for market effects. Humana is also undergoing legal investigation by Kahn Swick & Foti, LLC to probe its officers and directors. Meanwhile, the company appointed Michelle OβHara as its new
Chief Human Resources Officer and
Japan Mehta as Chief Information Officer amidst several management changes. It had some declines such as a 30% loss for its shareholders from last year's investment and a downgrade in their Medicare Plan Ratings; yet, the company also saw significant increases in holding by many including Swedbank AB, KBC Group NV, Washington Capital Management Inc, and others. However, even as Humana coyly boosts its earnings guidance and displays strength in Medicare and primary care, it drops early gains, diverging analyst expectations. Future performance remains an open question.
Humana HUM News Analytics from Wed, 31 Jul 2024 07:00:00 GMT to Sat, 01 Feb 2025 23:33:06 GMT -
Rating -3
- Innovation -6
- Information 7
- Rumor -8
